Upcoming Changes to Program-Specific Reports:
January 2013, July 2013, and January 2014
Removal of Pancreas Graft Survival
At the request of the OPTN Pancreas Committee and with the support of HRSA, SRTR
will remove pancreas graft survival metrics from all program-specific reports until
a consistent definition of pancreas graft failure is determined and in use. This
change will take place beginning with the January 2013 pancreas and kidney-pancreas
program-specific reports. SRTR will continue to calculate and release patient survival
All-Pancreas Outcomes Reporting
SRTR has developed all-pancreas outcomes reports using three pancreas models—pancreas
transplant alone (PTA), pancreas transplant after kidney transplant (PAK), and simultaneous
kidney-pancreas transplant (KP). These reports will include only patient survival
metrics until a consistent definition of pancreas graft failure is determined and
in use. Test versions of these reports have been provided to pancreas programs,
and the new pages will be included in the January 2014 public reports.
Waitlist Mortality by Adult and Pediatric Candidates
Beginning with the January 2012 public release, the program specific reports will
include Table 3A, which will depict transplant and mortality rates for pediatric
and adult candidates separately. Table 3 will still show the combined rates.
Graphical Format for the Transplant Program-Specific Reports
In addition to the traditional program-specific report, the SRTR will post a beta-release
of a new program-specific report to the SRTR secure websites on December 8, 2011.
This new report will not reflect the use of new methodologies; instead, it will
use color and an enhanced visual display to depict some of the content in the traditional
program-specific report. (Note that this beta-release is not intended to be a complete
version of the traditional program-specific report.) The SRTR will be seeking feedback
from transplant programs regarding the design and layout of this beta-release.
Upcoming Change to the OPO-Specific Reports:
January 2013 and July 2013
Lung Yield Model Modifications
Beginning with the January 2012 public release, Table 4 of the OPO-specific reports
contained measures of expected donor yield using the models approved by the OPTN/UNOS
Board in June 2011. The heart, liver, lung, and pancreas models used the lung pO2
terminal value as one of the modeling covariates. In the January and July 2013 reports,
this covariate will be changed to the lung pO2 terminal value divided by the FiO2
value. This change is in response to OPO feedback indicating that the ratio would
be more appropriate.
Expected Donor Yield Measures
Beginning with the January 2012 public release,
Table 4 of the OPO-specific reports will contain measures of expected donor yield
using the models approved by the OPTN/UNOS Board in June 2011 and by the OPTN Membership
and Professional Standards Committee in October 2011.
The OPO-specific reports privately released on the SRTR secure websites on December
8 will also include measures of observed and expected donor yield and whether the
OPO meets the review criteria established by the OPTN’s OPO and Membership and Professional
Standards Committees. The SRTR will be releasing a Donor Yield Calculator tool that
OPOs can use to track observed and expected donor yield. The tool will be made available
for download on the secure websites on December 8, 2011.